Wednesday, September 16, 2026Latest filing Sep 14, 2026

CVS Congressional Stock Trades

CVS HEALTH CORP CMN

Last disclosed trade Aug 24

Every disclosed trade in CVS by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

James French Hill · Sold $CVS · Jan 31 · $15K–$50K

0.65HIGH
Disclosure speedx 0.251.00
Trade sizex 0.250.50
Cluster activityx 0.150.30

1 other member traded this name in the same window.

Track recordx 0.350.67

Coldpine’s read

Hill sits on House Financial Services, giving him oversight relevance to CVS's insurance and pharmacy-benefit operations. The 4-day disclosure lag is fast, meaning the market may not have fully absorbed the filing. One other member traded CVS in the same direction within 30 days, indicating minor cluster activity.

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $CVS

Get notified when any member of Congress trades $CVS. Free, no card, no spam.

Follow free →
70
Disclosed trades
40
Buys
30
Sells
15
Members trading

The record on $CVS

Coldpine has parsed 70 disclosed trades in $CVS by 15 members of Congress, drawn from 48 periodic transaction reports dated Jul 1, 2021 through Aug 24, 2026. That is 67 trades from House members and 3 trades from senators, filed 47 by Democrats and 23 by Republicans.

Of the 70 trades with a known filing lag, 6 were reported more than 45 days after the trade date, outside the window the STOCK Act sets. The median lag was 28 days. The longest was 709 days: a $CVS sale by Thomas H Tuberville dated Aug 26, 2024, disclosed Aug 5, 2026. How late filing is measured across all of Congress is in the late-filers study.

55 of the 65 trades that list an account holder (85%) were reported under a spouse, dependent child, or joint account rather than the member directly.

Rohit Khanna filed the most $CVS purchases (25), and Rohit Khanna the most sales (12).

Activity peaked in 2023 with 25 trades. The busiest single month was January 2025, when 4 different members disclosed $CVS trades. In 1 calendar month out of 33 with activity, three or more members bought $CVS in the same month, the same-direction overlap Coldpine's cluster detector looks for.

Across the 40 purchases Coldpine can price, $CVS moved +3.26% on average between the trade date and the disclosure date, against +2.40% for the S&P 500 over the same windows. The stock was higher at disclosure than at the trade in 55% of those purchases. That is a record of what already happened, not a forecast. Method: what stocks do before Congress discloses.

Members who trade CVS

Recent disclosed trades in CVS

DateMemberTypeAmount
Aug 24Rohit Khanna(CA)sell$1K–$15K
Jun 2Rohit Khanna(CA)buy$1K–$15K
Apr 13Rohit Khanna(CA)buy$1K–$15K
Mar 27Alan Armstrong(OK)buy$1K–$15K
Feb 20Michael T. McCaul(TX)buy$15K–$50K
Jan 29John Boozman(AR)buy$1K–$15K
Jan 13Michael T. McCaul(TX)sell$15K–$50K
Nov 21Dwight Evans(PA)sell$1K–$15K
Nov 21Dwight Evans(PA)sell$1K–$15K
Oct 27Michael T. McCaul(TX)sell$15K–$50K
Aug 22Michael T. McCaul(TX)sell$50K–$100K
Aug 8Adam Smith(WA)sell$1K–$15K
Aug 4Rohit Khanna(CA)buy$1K–$15K
May 28Rohit Khanna(CA)buy$1K–$15K
May 19Rohit Khanna(CA)buy$1K–$15K
May 15Rob Bresnahan(PA)sell$1K–$15K
Apr 10Michael T. McCaul(TX)sell$100K–$250K
Mar 12Rohit Khanna(CA)buy$1K–$15K
Mar 6Rohit Khanna(CA)buy$1K–$15K
Jan 31James French Hill(AR)sell$15K–$50K

Showing 20 of 70 disclosed trades.

Sign up free for the full history, signal scores, the price-vs-trades chart, and Coldpine's read (the AI narrative on each trade).

Create a free account

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →